← Back to Clinical Trials
RecruitingPhase 4NCT05598398

NPWTi on Closure of Chronic Pressure Sores

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionPressure Sore
SponsorNorthwestern University
Study TypeINTERVENTIONAL
PhasePhase 4
Enrollment62
SexALL
Min Age18 Years
Max AgeN/A
Start Date2022-09-26
Completion2027-01
Interventions
V.A.C.Ulta™ Negative Pressure Wound Therapy SystemStandard of Care (Wet-to-dry dressings)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The primary objective of this study is to assess the effectiveness of the Negative Pressure Wound Therapy system with instillation therapy (NPWTi) on closure of chronic pressure sores. This intervention will be compared to wet-to-dry dressings, which is standard of care. In this post-market, on-label study, we hope to show that the NPWTi system more effectively closes pressure sores following debridement than traditional care.

Eligibility Criteria

Inclusion Criteria: 1. Ischial and sacral wounds at stage 3 and 4. 2. Any pressure sore that has the potential for a good seal. Exclusion Criteria: 1. Any pressure sore that does not have potential for a good seal. 2. Patients with fecal incontinence (due to potential for pressure sore to be near the anus). 3. Patients who by the opinion of the Principal Investigator are not candidates for surgical closure (age, BMI, comorbidities, etc.). 4. Patients who are pregnant. This is standard of care for surgery anyway, and there is uncertainty of how both the surgery and intervention would affect the fetus. We therefore stress any form of birth control, abstinence, and method to prevent pregnancy for those enrolled in the study.

Related Trials